Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine E Muehlenbein

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemotherapy Research and Practice|April 7, 2012
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancerCrystal T Pike, Howard G Birnbaum, Catherine E Muehlenbein, et al.
Journal of Clinical Epidemiology|October 17, 2007
Methodological issues in design and analysis of a matched case-control study of a vaccine's effectivenessLinda M Niccolai, Lorraine G Ogden, Catherine E Muehlenbein, et al.
American Journal of Public Health|April 9, 2020
Debunking Myths While Understanding LimitationsLisa M Hess, Katherine B Winfree, Catherine E Muehlenbein, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2021
Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189Edward B Garon, Joachim Aerts, Jong Seok Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 17, 2023
Corrigendum to "Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189" [Lung Cancer 155 (2021) 53-60]Edward B Garon, Joachim Aerts, Jong Seok Kim, et al.
Advances in Therapy|October 21, 2018
Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database AnalysisKathleen M Aguilar, Katherine B Winfree, Catherine E Muehlenbein, et al.
BMC Cancer|August 13, 2024
Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United StatesSophie Peloquin, Florence Cymbalista, Martin Dreyling, et al.
JAMA|February 19, 2004
Effectiveness over time of varicella vaccineMarietta Vázquez, Philip S LaRussa, Anne A Gershon, et al.
Journal of Cancer Epidemiology|July 19, 2011
Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung CancerCatherine E Muehlenbein, J Russell Hoverman, Stephen K Gruschkus, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemotherapy Research and Practice|April 7, 2012
Healthcare costs and workloss burden of patients with chemotherapy-associated peripheral neuropathy in breast, ovarian, head and neck, and nonsmall cell lung cancerCrystal T Pike, Howard G Birnbaum, Catherine E Muehlenbein, et al.
Journal of Clinical Epidemiology|October 17, 2007
Methodological issues in design and analysis of a matched case-control study of a vaccine's effectivenessLinda M Niccolai, Lorraine G Ogden, Catherine E Muehlenbein, et al.
American Journal of Public Health|April 9, 2020
Debunking Myths While Understanding LimitationsLisa M Hess, Katherine B Winfree, Catherine E Muehlenbein, et al.
Lung Cancer (Amsterdam, Netherlands)|March 17, 2021
Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189Edward B Garon, Joachim Aerts, Jong Seok Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 17, 2023
Corrigendum to "Safety of pemetrexed plus platinum in combination with pembrolizumab for metastatic nonsquamous non-small cell lung cancer: A post hoc analysis of KEYNOTE-189" [Lung Cancer 155 (2021) 53-60]Edward B Garon, Joachim Aerts, Jong Seok Kim, et al.
Advances in Therapy|October 21, 2018
Treatment Patterns by EGFR Mutation Status in Non-Small Cell Lung Cancer Patients in the USA: A Retrospective Database AnalysisKathleen M Aguilar, Katherine B Winfree, Catherine E Muehlenbein, et al.
BMC Cancer|August 13, 2024
Knowledge, skills, and confidence gaps impacting treatment decision making in relapsed/refractory chronic lymphocytic leukemia and mantle cell lymphoma: a quantitative survey study in France, Germany, and the United StatesSophie Peloquin, Florence Cymbalista, Martin Dreyling, et al.
JAMA|February 19, 2004
Effectiveness over time of varicella vaccineMarietta Vázquez, Philip S LaRussa, Anne A Gershon, et al.
Journal of Cancer Epidemiology|July 19, 2011
Evaluation of the Reliability of Electronic Medical Record Data in Identifying Comorbid Conditions among Patients with Advanced Non-Small Cell Lung CancerCatherine E Muehlenbein, J Russell Hoverman, Stephen K Gruschkus, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Pageof 2